Xy Capital LTD Johnson & Johnson Call Options Transaction History

Xy Capital LTD

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 05, 2024	BUY	$144.38 - $157.78 $967,346 - $1.06 Million	6,700 Added 134.0%	11,700 $1.71 Billion
Q1 2024 Apr 29, 2024	SELL	$155.22 - $162.74 $388,050 - $406,850	-2,500 Reduced 33.33%	5,000 $791 Million
Q4 2023 Jan 24, 2024	SELL	$145.6 - $158.88 $524,160 - $571,968	-3,600 Reduced 32.43%	7,500 $1.18 Billion
Q3 2023 Nov 01, 2023	BUY	$155.75 - $174.48 $1.73 Million - $1.94 Million	11,100 New	11,100 $1.73 Billion

4,272

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Xy Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Xy Capital LTD with notifications on news.